Clinical Trial Update: Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions [NA]

View source ↗

Summary

Clinical trial update comparing Augment Injectable Bone Graft to autologous bone graft for hindfoot fusions; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Congenital Deformity
• Degenerative Joint Disease
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Augment Injectable Bone Graft

Snippet

Sponsor: BioMimetic Therapeutics | Conditions: Degenerative Joint Disease, Congenital Deformity | NA | Status: COMPLETED | Results posted: 2018-12-05